Free Trial

Acurx Pharmaceuticals (ACXP) SEC Filings & 10K Form

Acurx Pharmaceuticals logo
$0.78 +0.10 (+14.72%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.78 -0.01 (-0.84%)
As of 02/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Acurx Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/06/2025
11:15 PM
Acurx Pharmaceuticals (Filer)
Form EFFECT
02/06/2025
4:47 PM
Acurx Pharmaceuticals (Issuer)
Shawah Robert G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
4:45 PM
Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
4:46 PM
Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:11 PM
Acurx Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:32 PM
Acurx Pharmaceuticals (Issuer)
Scodari Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:30 PM
Acurx Pharmaceuticals (Issuer)
DEAN JACK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:30 PM
Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
Donohue James J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
9:00 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
9:03 AM
Acurx Pharmaceuticals (Filer)
Form 424B5
01/06/2025
2:51 PM
Acurx Pharmaceuticals (Filer)
Form 424B3
11/13/2024
6:06 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:13 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:13 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM
Acurx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/03/2024
8:55 PM
Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:56 PM
Acurx Pharmaceuticals (Issuer)
Shawah Robert G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:56 PM
Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:31 AM
Acurx Pharmaceuticals (Subject)
Form FWP
03/29/2024
3:58 PM
Acurx Pharmaceuticals (Filer)
Form S-1/A
03/15/2024
3:33 PM
Acurx Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ACXP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners